Table of Contents
ISRN Infectious Diseases
Volume 2013 (2013), Article ID 518205, 5 pages
http://dx.doi.org/10.5402/2013/518205
Clinical Study

Prevalence and Utility of Positive Pneumococcal Urinary Antigen Tests in Australian Patients with Community-Acquired Pneumonia

1Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Missenden Road Camperdown, Sydney, NSW 2043, Australia
2Sydney Medical School, University of Sydney, Sydney, NSW 2006, Australia
3Woolcock Institute of Medical Research, Glebe, NSW 2037, Australia

Received 10 July 2012; Accepted 9 August 2012

Academic Editors: F. Su, N. Uchide, and P. Viale

Copyright © 2013 Lauren K. Troy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. The Victorian Admitted Episodes Dataset: An Overview April 2000, Acute Health Division, Victorian Government Department of Human Services, Melbourne, Victoria, 2000.
  2. Respiratory Infectious Diseases Consultative Group, Respiratory Infectious Diseases Burden in Australia Case Statement, The Australian Lung Foundation, 1st edition, 2007.
  3. G. W. Waterer, L. A. Kessler, and R. G. Wunderink, “Medium-term survival after hospitalization with community-acquired pneumonia,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 8, pp. 910–914, 2004. View at Google Scholar · View at Scopus
  4. S. Yende, D. C. Angus, I. S. Ali et al., “Influence of comorbid conditions on long-term mortality after pneumonia in older people,” Journal of the American Geriatrics Society, vol. 55, no. 4, pp. 518–525, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. Antibiotic Expert Group, Therapeutic Guidelines: Antibiotic, Version 14, Therapeutic Guidelines Limited, Melbourne, Victoria, 2010.
  6. J. Domínguez, N. Galí, S. Blanco et al., “Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples,” Chest, vol. 119, no. 1, pp. 243–249, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. D. R. Murdoch, R. T. R. Laing, G. D. Mills et al., “Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia,” Journal of Clinical Microbiology, vol. 39, no. 10, pp. 3495–3498, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Kobashi, K. Yoshida, N. Miyashita, Y. Niki, and T. Matsushima, “Evaluating the use of a Streptococcus pneumoniae urinary antigen detection kit for the management of community-acquired pneumonia in Japan,” Respiration, vol. 74, no. 4, pp. 387–393, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Ishida, T. Hashimoto, M. Arita, Y. Tojo, H. Tachibana, and M. Jinnai, “A 3-year prospective study of a urinary antigen-detection test for Streptococcus pneumoniae in community-acquired pneumonia: utility and clinical impact on the reported etiology,” Journal of Infection and Chemotherapy, vol. 10, no. 6, pp. 359–363, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Marcos, J. de Anta, J. P. de la Bellacasa et al., “Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults,” European Respiratory Journal, vol. 21, no. 2, pp. 209–214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Sordé, V. Falcó, M. Lowak et al., “Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy,” Archives of Internal Medicine, vol. 171, no. 2, pp. 166–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. L. Briones, J. Blanquer, D. Ferrando, M. L. Blasco, C. Gimeno, and J. Marín, “Assessment of analysis of urinary pneumococcal antigen by immunochromatography for etiologic diagnosis of community-acquired pneumonia in adults,” Clinical and Vaccine Immunology, vol. 13, no. 10, pp. 1092–1097, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. R. Boulware, C. L. Daley, C. Merrifield, P. C. Hopewell, and E. N. Janoff, “Rapid diagnosis of pneumococcal pneumonia among HIV-infected adults with urine antigen detection,” Journal of Infection, vol. 55, no. 4, pp. 300–309, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Lasocki, A. Scanvic, F. le Turdu et al., “Evaluation of the Binax NOW Streptococcus pneumoniae urinary antigen assay in intensive care patients hospitalized for pneumonia,” Intensive Care Medicine, vol. 32, no. 11, pp. 1766–1772, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. J. P. Watt, J. C. Moïsi, R. L. A. Donaldson et al., “Use of serology and urine antigen detection to estimate the proportion of adult community-acquired pneumonia attributable to Streptococcus pneumoniae,” Epidemiology and Infection, vol. 138, no. 12, pp. 1796–1803, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. P. G. P. Charles, M. Whitby, A. J. Fuller et al., “The etiology of community-acquired pneumonia in Australia: Why penicillin plus doxycycline or a macrolide is the most appropriate therapy,” Clinical Infectious Diseases, vol. 46, no. 10, pp. 1513–1521, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. W. S. Lim, S. V. Baudouin, R. C. George et al., “British thoracic society guidelines for the management of community acquired pneumonia in adults: update 2009,” Thorax, vol. 64, no. 3, pp. iii1–iii55, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. L. A. Mandell, R. G. Wunderink, A. Anzueto et al., “Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the management of community-acquired pneumonia in adults,” Clinical Infectious Diseases, vol. 44, no. 2, pp. S27–S72, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. I. Restrepo, E. M. Mortensen, G. W. Waterer, R. G. Wunderink, J. J. Coalson, and A. Anzueto, “Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia,” European Respiratory Journal, vol. 33, no. 1, pp. 153–159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. M. M. van der Eerden, F. Vlaspolder, C. S. de Graaff et al., “Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study,” Thorax, vol. 60, no. 8, pp. 672–678, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. W. S. Lim, M. M. van der Eerden, R. Laing et al., “Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study,” Thorax, vol. 58, no. 5, pp. 377–382, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Andreo, J. Domínguez, J. Ruiz et al., “Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults,” Respiratory Medicine, vol. 100, no. 5, pp. 884–891, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Gil-Prieto, L. Garcia-Garcia, A. Alvaro-Meca, C. Méndez, A. García, and A. Gil de Miguel, “The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003–2007),” Vaccine, vol. 29, no. 3, pp. 412–416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Lim, D. R. Shaw, D. P. Stanley, R. Lumb, and G. McLennan, “A prospective hospital study of the aetiology of community-acquired pneumonia,” Medical Journal of Australia, vol. 151, no. 2, pp. 87–91, 1989. View at Google Scholar · View at Scopus
  25. M. M. van der Eerden, F. Vlaspolder, C. S. de Graaff, T. Groot, H. M. Jansen, and W. G. Boersma, “Value of intensive diagnostic microbiological investigation in low- and high-risk patients with community-acquired pneumonia,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 24, no. 4, pp. 241–249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. J. P. Nuorti, J. C. Butler, M. M. Farley et al., “Cigarette smoking and invasive pneumococcal disease,” New England Journal of Medicine, vol. 342, no. 10, pp. 681–689, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Feldman and R. Anderson, “New insights into pneumococcal disease,” Respirology, vol. 14, no. 2, pp. 167–179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. T. van der Poll and S. M. Opal, “Pathogenesis, treatment, and prevention of pneumococcal pneumonia,” The Lancet, vol. 374, no. 9700, pp. 1543–1556, 2009. View at Publisher · View at Google Scholar · View at Scopus